EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC-ND 4.0

Development and Validation of an Approach to Assessing Clinical Relevance of Potential Drug–Drug Interactions Inducing Rare but Serious Adverse Events

Menghuan Song iD, Hui Zhou, Zhirong Yang, Yunfeng Lai, Carolina Oi Lam Ung, Hao Hu

Clinical and Translational Science · 2025

DOI: 10.1111/cts.70253 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Clinical and Translational Science, 2025. Verfasst von Menghuan Song und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Ta…. Hauptthemen laut MEDLINE: Long QT Syndrome, Drug-Related Side Effects and Adverse Reactions. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Evaluating clinical relevance of potential drug–drug interactions is significant for managing safety risks. However, current approaches to the evaluation lack data on rare but serious adverse events. This study aims to develop an approach to assessing clinical relevance of potential drug–drug interactions that induce rare and serious adverse events, and test its performance. In the development, three key dimensions for evaluating clinical relevance were synthesized based on a literature review. A systematic five‐step approach was proposed through designated dimensions and discussions within the research team. Subsequently, the approach was applied to patients with depression to validate its ability of demonstrating the dimensions, and exacting data on rare but serious adverse events. The test results showed varying signal intensities among different drug combinations in relation to adverse events including serotonin syndrome, long QT syndrome, and Torsade de Pointes. Advanced age was identified as a confounding factor for the QT prolongation signal. These findings operationalize Dimension one: Probabilities and risk factors for the occurrence of rare and serious adverse events. Besides, in the test, fatality occurred in 22.01% of the cases having drug‐triggered QT prolongation. Advancing age was associated with the fatality (odds ratio = 1.03, 95% confidence interval = 1.01–1.07). The findings manifested Dimension two: Magnitude of adverse events and associated factors. Dimension three was achieved by findings of median time‐to‐onset of fatal serotonin syndrome and QT prolongation, which was one and 8 days, respectively. In summary, the proposed approach demonstrates effects in assessing the clinical relevance of potential drug–drug interactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Long QT SyndromeDrug-Related Side Effects and Adverse ReactionsHumansDrug InteractionsRisk FactorsMiddle AgedFemaleMaleSerotonin SyndromeTorsades de PointesAdultAgedRisk AssessmentAge FactorsAntidepressive AgentsDepressionClinical Relevance

Stichwörter der Autor:innen

DDIa systematic approachclinical relevancedepressionpharmacoepidemiologypharmacovigilance

Substanzen

Antidepressive Agents

Autor:innen und Institutionen

  • State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macao Special Administrative Region, China.
  • Centre for Pharmaceutical Regulatory Sciences, University of Macau, Avenida da Universidade, Taipa, Macao Special Administrative Region, China.
  • Department of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Department of Computational Biology and Medical Big Data, Shenzhen University of Advanced Technology, Shenzhen, China.
  • Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
  • School of Public Health and Management, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.

ORCID-Profile: Menghuan Song

Zitieren

APA

Song, M., Zhou, H., Yang, Z., Lai, Y., Ung, C. O. L., & Hu, H. (2025). Development and Validation of an Approach to Assessing Clinical Relevance of Potential Drug–Drug Interactions Inducing Rare but Serious Adverse Events. Clinical and Translational Science. https://doi.org/10.1111/cts.70253

Vancouver

Song M, Zhou H, Yang Z, Lai Y, Ung COL, Hu H. Development and Validation of an Approach to Assessing Clinical Relevance of Potential Drug–Drug Interactions Inducing Rare but Serious Adverse Events. Clinical and Translational Science. 2025. doi:10.1111/cts.70253

BibTeX
@article{Song2025,
  author = {Song, Menghuan and Zhou, Hui and Yang, Zhirong and Lai, Yunfeng and Ung, Carolina Oi Lam and Hu, Hao},
  title = {Development and Validation of an Approach to Assessing Clinical Relevance of Potential Drug–Drug Interactions Inducing Rare but Serious Adverse Events},
  journal = {Clinical and Translational Science},
  year = {2025},
  doi = {10.1111/cts.70253}
}
Kostenlos starten →